EUVIMEDEUVIMED entdecken
Crossref

Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver disease

Sofia Manioudaki, Larisa Vasilieva, Eleni Geladari, Iliana Mani, Vasilios Sevastianos, Filia Diamantea, Alexandra Alexopoulou

Journal of Cystic Fibrosis · 2026

DOI: 10.1016/j.jcf.2026.06.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Sofia Manioudaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, Sismanogleio General Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Cystic Fibrosis, Fatty Liver. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIMS: Hepatic steatosis (HS) is common in Cystic fibrosis (CF). CF transmembrane conductance-regulator (CFTR) modulators have been associated with improved nutritional status. The controlled attenuation parameter (CAP) is a non-invasive method for assessing HS. This study aimed to evaluate HS and to investigate whether its presence is associated with features suggestive of metabolic dysfunction-associated steatotic liver disease (MASLD). METHODS: We conducted a prospective study (duration 25±2.5 months) including 45 patients receiving elexacaftor/tezacaftor/ivacaftor (treatment duration 32.7 ± 9.9 months). Clinical and laboratory data, as well as non-invasive markers of liver fibrosis, were recorded at enrolment and at final assessment (FA). RESULTS: From enrolment to FA, body mass index (BMI) increased significantly (p < 0.001), whereas HS either persisted or developed during follow-up. At FA, BMI and waist circumference were associated with HS in univariate analysis; however, in multivariate analysis, only BMI remained independently associated with HS [OR 1.338 (95%CI 1.064-1.682), p = 0.013]. Among 12 (26.6%) patients with CAP≥248 dB/m at FA, all but one fulfilled at least one cardiometabolic criterion for MASLD. Overall, liver stiffness measurement and AST-to-Platelet-Ratio Index decreased at FA compared with enrolment (p = 0.044 and p = 0.027, respectively). This improvement persisted after BMI stratification only in patients with BMI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisFatty LiverHumansFemaleMaleAdultProspective StudiesCystic Fibrosis Transmembrane Conductance RegulatorBody Mass IndexAminophenolsQuinolonesBenzodioxolesIndolesElasticity Imaging TechniquesChloride Channel AgonistsPropionatesPyrrolidines

Stichwörter der Autor:innen

Controlled attenuation parameterCystic fibrosis hepato-biliary involvementLiver stiffnessMetabolic dysfunction-associated steatotic liver disease

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorAminophenolsQuinolonesBenzodioxolesIndolestezacaftorChloride Channel AgonistsPropionatesPyrrolidines

Autor:innen und Institutionen

  • Intensive Care Unit, Sismanogleio General Hospital, Athens, Greece.
  • Department of Gastroenterology, Alexandra General Hospital, Athens, Greece.
  • 3rd Department of Internal Medicine and Liver Outpatient Clinic, Evangelismos General Hospital, Athens, Greece.
  • 2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
  • Adult Cystic Fibrosis (CF) Unit, Sismanoglio Hospital, Athens, Greece.
  • 2nd Department of Internal Medicine and Research Laboratory, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece. Electronic address: alexopou@ath.forthnet.gr.

Zitieren

APA

Manioudaki, S., Vasilieva, L., Geladari, E., Mani, I., Sevastianos, V., Diamantea, F., & Alexopoulou, A. (2026). Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver disease. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.06.008

Vancouver

Manioudaki S, Vasilieva L, Geladari E, Mani I, Sevastianos V, Diamantea F, et al. Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver disease. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.06.008

BibTeX
@article{Manioudaki2026,
  author = {Manioudaki, Sofia and Vasilieva, Larisa and Geladari, Eleni and Mani, Iliana and Sevastianos, Vasilios and Diamantea, Filia and Alexopoulou, Alexandra},
  title = {Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver disease},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  doi = {10.1016/j.jcf.2026.06.008}
}
Kostenlos starten →